Cross divests Micromacinazione to trade investor Lonza

Financial details surrounding the transaction remain undisclosed. The fund manager has fully exit its investment after five-year holding period.

Previous funding
Cross acquired a majority stake in the business in July 2012 via its maiden vehicle Cross. The 2009-vintage fund held a final close on CHF 100m in November 2010.

Company
Founded in 1970, Micromacinazione manufactures technology and provides services for the pharmaceuticals and fine chemicals industries. The company is headquartered in Molinazzo di Monteggio and focuses on micronisation of active pharmaceutical ingredients, as well as the production of micronisation facilities and isolators.

The business posted a turnover of CHF 20m in 2016 and employs 120 people.

People
Cross Equity Partners – Michael Petersen (managing partner); Markus Reich (partner).
Micromacinazione – Markus Arigoni (CEO).

Advisers
Vendor – GCA Altium (corporate finance); Wenger & Vieli (legal).
Acquirer – PwC (financial due diligence); Baer & Karrer (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• DACH
• Industrials
• Trade sale
• Switzerland
• Cross Equity Partners AG